Low nanogel stiffness favors nanogel transcytosis across an in vitro blood-brain barrier (2021)
Ribovski, Laís 
; Jong, Edwin de; Mergel, Olga; Zu, Guangyue; Keskin, Damla; Rijn, Patrick van ; Zuhorn, Inge S.
Source: Nanomedicine: Nanotechnology, Biology, and Medicine. Unidade: IFSC
Subjects: DOENÇAS CEREBRAIS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBOVSKI, Laís et al. Low nanogel stiffness favors nanogel transcytosis across an in vitro blood-brain barrier. Nanomedicine: Nanotechnology, Biology, and Medicine, v. 34, p. 102377-1-102377-11 + supplementary data, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2021.102377. Acesso em: 30 jul. 2024.APA
Ribovski, L., Jong, E. de, Mergel, O., Zu, G., Keskin, D., Rijn, P. van, & Zuhorn, I. S. (2021). Low nanogel stiffness favors nanogel transcytosis across an in vitro blood-brain barrier. Nanomedicine: Nanotechnology, Biology, and Medicine, 34, 102377-1-102377-11 + supplementary data. doi:10.1016/j.nano.2021.102377NLM
Ribovski L, Jong E de, Mergel O, Zu G, Keskin D, Rijn P van, Zuhorn IS. Low nanogel stiffness favors nanogel transcytosis across an in vitro blood-brain barrier [Internet]. Nanomedicine: Nanotechnology, Biology, and Medicine. 2021 ; 34 102377-1-102377-11 + supplementary data.[citado 2024 jul. 30 ] Available from: https://doi.org/10.1016/j.nano.2021.102377Vancouver
Ribovski L, Jong E de, Mergel O, Zu G, Keskin D, Rijn P van, Zuhorn IS. Low nanogel stiffness favors nanogel transcytosis across an in vitro blood-brain barrier [Internet]. Nanomedicine: Nanotechnology, Biology, and Medicine. 2021 ; 34 102377-1-102377-11 + supplementary data.[citado 2024 jul. 30 ] Available from: https://doi.org/10.1016/j.nano.2021.102377
